These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8059803)

  • 21. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.
    Mujal A; Sola J; Hernandez M; Villarino MA; Machado ML; Baylina M; Tajan J; Oristrell J
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1125-33. PubMed ID: 25655757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical studies of cefotaxime, administration in intravenous drip infusion, for infectious diseases in the field of obstetrics and gynecology (author's transl)].
    Hagiwara K
    Jpn J Antibiot; 1981 Apr; 34(4):500-6. PubMed ID: 6270398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review.
    Bryant PA; Katz NT
    Lancet Infect Dis; 2018 Feb; 18(2):e45-e54. PubMed ID: 28822781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefotaxime optimal dosage in adult patients. A reappraisal.
    Simon A; d'Aubrac CA; Safran C; Carbon C
    Drugs; 1988; 35 Suppl 2():221-30. PubMed ID: 3293977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].
    Manncke K; Springsklee M; Heizmann WR; Sonntag HG
    Med Klin (Munich); 1991 Sep; 86(9):454-60. PubMed ID: 1943983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
    Holloway WJ; Palmer D
    Am J Med; 1996 Jun; 100(6A):52S-59S. PubMed ID: 8678098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.
    Nathwani D
    Drugs; 2000; 59 Suppl 3():37-46; discussion 47-9. PubMed ID: 10845412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care.
    Grayson ML; Silvers J; Turnidge J
    Med J Aust; 1995 Mar; 162(5):249-53. PubMed ID: 7891605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
    Sen RA; Keaney MG; Ganguli LA
    J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of lower respiratory tract infections including pneumonia. Comparative study with i.vl cefotaxime/oral cefixime versus parenteral cefotaxime].
    Vogel F
    Fortschr Med; 1994 Oct; 112(28):395-8. PubMed ID: 7988978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of intravenous ciprofloxacin and intravenous cefotaxime for antimicrobial prophylaxis in transurethral surgery.
    Cox CE
    Am J Med; 1989 Nov; 87(5A):252S-254S. PubMed ID: 2686427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twice daily ceftriaxone therapy for serious bacterial infections in children.
    Chonmaitree T; Congeni BL; Munoz J; Rakusan TA; Powell KR; Box QT
    J Antimicrob Chemother; 1984 May; 13(5):511-6. PubMed ID: 6330022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors.
    Leroy O; Saux P; Bédos JP; Caulin E
    Chest; 2005 Jul; 128(1):172-83. PubMed ID: 16002932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study.
    Rowe-Jones DC; Peel AL; Kingston RD; Shaw JF; Teasdale C; Cole DS
    BMJ; 1990 Jan; 300(6716):18-22. PubMed ID: 2105115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambulatory antibiotic infusion devices: extending the spectrum of outpatient therapies.
    New PB; Swanson GF; Bulich RG; Taplin GC
    Am J Med; 1991 Nov; 91(5):455-61. PubMed ID: 1951407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.